Changing from NAFLD to MASLD: Similar prognosis of patients with HCC under atezolizumab/bevacizumab treatment between NAFLD and MASLD
- Author:
Hiroyuki SUZUKI
1
;
Shigeo SHIMOSE
;
Hideki IWAMOTO
;
Takashi NIIZEKI
;
Takumi KAWAGUCHI
Author Information
- Publication Type:Letter to the Editor
- From:Clinical and Molecular Hepatology 2024;30(2):263-265
- CountryRepublic of Korea
- Language:English
